Detalles de la búsqueda
1.
Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination.
Cancer Immunol Immunother
; 72(1): 183-191, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35779095
2.
Pharmacokinetics and Biodistribution of a [89Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients.
Mol Pharm
; 16(7): 3083-3090, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31117485
3.
Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol.
Bioorg Med Chem
; 22(21): 5917-23, 2014 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25284254
4.
Effect of Oral ß-Glucan on Antibody Response to Ganglioside Vaccine in Patients With High-Risk Neuroblastoma: A Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 9(2): 242-250, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36547975
5.
Synthesis and preclinical evaluation of QS-21 variants leading to simplified vaccine adjuvants and mechanistic probes.
J Am Chem Soc
; 134(32): 13448-57, 2012 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22866694
6.
Immunization with N-propionyl polysialic acid-KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci.
Cancer Immunol Immunother
; 61(1): 9-18, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21811785
7.
A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery.
Eur J Cancer
; 176: 155-163, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36215947
8.
Impact of minimal tumor burden on antibody response to vaccination.
Cancer Immunol Immunother
; 60(5): 621-7, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21267719
9.
The known immunologically active components of Astragalus account for only a small proportion of the immunological adjuvant activity when combined with conjugate vaccines.
Planta Med
; 77(8): 817-24, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21128203
10.
Phase I Trial of Oral Yeast-Derived ß-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma.
Cancers (Basel)
; 13(24)2021 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34944886
11.
Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression.
J Clin Oncol
; 39(3): 215-226, 2021 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33326254
12.
Design and synthesis of potent Quillaja saponin vaccine adjuvants.
J Am Chem Soc
; 132(6): 1939-45, 2010 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-20088518
13.
Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer.
Blood
; 112(4): 1308-16, 2008 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18535199
14.
Biologics through chemistry: total synthesis of a proposed dual-acting vaccine targeting ovarian cancer by orchestration of oligosaccharide and polypeptide domains.
J Am Chem Soc
; 131(11): 4151-8, 2009 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-19253940
15.
From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine.
J Am Chem Soc
; 131(26): 9298-303, 2009 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-19518111
16.
Synthesis of sialyl Lewis(a) (sLe (a), CA19-9) and construction of an immunogenic sLe(a) vaccine.
Cancer Immunol Immunother
; 58(9): 1397-405, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19190907
17.
Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using 89Zr-DFO-MSTP2109A Anti-STEAP1 Antibody.
J Nucl Med
; 60(11): 1517-1523, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31053681
18.
Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T-cell ligand.
Immunology
; 123(1): 145-55, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18154620
19.
Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21.
Clin Cancer Res
; 13(10): 2977-85, 2007 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17504999
20.
Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer.
Clin Cancer Res
; 13(14): 4170-7, 2007 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17634545